GPBAR1 and Cholestatic liver disease: Research indicates that TGR5 mitigates reactive oxygen species (ROS) generation by inhibiting the NF-κB signaling pathway and activating the Nrf2/HO-1 pathway, which promotes the expression of antioxidant enzymes and offers protection against cholestatic liver disease induced by bile duct ligation [65].